Publication: Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
Loading...
Date
Advisor
Coadvisor
Graduate program
Undergraduate course
Journal Title
Journal ISSN
Volume Title
Publisher
Type
Article
Access right
Acesso restrito
Abstract
It has been demonstrated that histamine interferes with the recruitment, formation and activity of osteoclasts via H1- and H2-receptors. Cimetidine is a H2-receptor antagonist used for treatment of gastric ulcers that seems to prevent bone resorption. In this study, a possible cimetidine interference was investigated in the number of alveolar bone osteoclasts. The incidence of osteoclast apoptosis and immunoexpression of RANKL (receptor activator of nuclear factor κB ligand) was also evaluated. Adult male rats were treated with 100mg kg-1 of cimetidine for 50days (CimG); the sham group (SG) received saline. Maxillary fragments containing the first molars and alveolar bone were fixed, decalcified and embedded in paraffin. The sections were stained by H&E or submitted to tartrate-resistant acid phosphatase (TRAP) method. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling) method and immunohistochemical reactions for detecting caspase-3 and RANKL were performed. The number of TRAP-positive osteoclasts, the frequency of apoptotic osteoclasts and the numerical density of RANKL-positive cells were obtained. Osteoclast death by apoptosis was confirmed by transmission electron microscopy (TEM). In CimG, TRAP-positive osteoclasts with TUNEL-positive nuclei and caspase-3-immunolabeled osteoclasts were found. A significant reduction in the number of TRAP-positive osteoclasts and a high frequency of apoptotic osteoclasts were observed in CimG. Under TEM, detached osteoclasts from the bone surface showed typical features of apoptosis. Moreover, a significant reduction in the numerical density of RANKL-positive cells was observed in CimG. The significant reduction in the number of osteoclasts may be due to cimetidine-induced osteoclast apoptosis. However, RANKL immunoexpression reduction also suggests a possible interference of cimetidine treatment in the osteoclastogenesis. © 2012 The Authors Journal of Anatomy © 2012 Anatomical Society.
Description
Keywords
Alveolar bone, Apoptosis, Cimetidine, Osteoclast, Osteoclastogenesis, acid phosphatase tartrate resistant isoenzyme, caspase 3, cimetidine, hycimet, osteoclast differentiation factor, unclassified drug, alveolar bone, animal cell, animal experiment, animal tissue, apoptosis, bone demineralization, cell count, cell density, controlled study, immunohistochemistry, incidence, male, maxilla, molar tooth, nick end labeling, nonhuman, osteoclast, periodontium, priority journal, protein expression, rat, transmission electron microscopy, treatment duration, Animals, Histamine H2 Antagonists, Immunohistochemistry, In Situ Nick-End Labeling, Male, Microscopy, Electron, Transmission, Osteoclasts, Periodontium, RANK Ligand, Rats, Rattus
Language
English
Citation
Journal of Anatomy, v. 222, n. 2, p. 239-247, 2013.
